We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPE icon
151
Hewlett Packard
HPE
$63.2B
$99.6M 0.12%
4,663,146
+968,467
+26% +$20.4M
ISRG icon
152
Intuitive Surgical
ISRG
$121B
$99.3M 0.12%
190,169
-242,562
-56% -$126M
SPGI icon
153
S&P Global
SPGI
$126B
$98.2M 0.12%
197,270
+92,650
+89% +$47M
OKE icon
154
Oneok
OKE
$58.7B
$97.6M 0.12%
971,913
+713,685
+276% +$73M
CNK icon
155
Cinemark Holdings
CNK
$3.82B
$96.8M 0.12%
3,124,834
+396,720
+15% +$12.3M
UAL icon
156
United Airlines
UAL
$38.4B
$96.3M 0.12%
991,432
-563,815
-36% -$47.7M
COP icon
157
ConocoPhillips
COP
$147B
$95M 0.11%
+957,973
New +$102M
JLL icon
158
Jones Lang LaSalle
JLL
$15.1B
$94.5M 0.11%
373,207
+214,087
+135% +$57.1M
COST icon
159
Costco
COST
$415B
$94.4M 0.11%
103,077
+101,099
+5,111% +$93.8M
ED icon
160
Consolidated Edison
ED
$41.6B
$94M 0.11%
1,053,339
+736,348
+232% +$72.5M
GMED icon
161
Globus Medical
GMED
$10.4B
$94M 0.11%
1,136,266
+486,756
+75% +$38.4M
WFC icon
162
Wells Fargo
WFC
$261B
$93.8M 0.11%
1,335,000
+917,103
+219% +$62.6M
AS icon
163
Amer Sports
AS
$19.7B
$92.7M 0.11%
3,316,167
+2,401,302
+262% +$52.9M
CAVA icon
164
CAVA Group
CAVA
$7.22B
$92.1M 0.11%
816,837
-1,127,114
-58% -$150M
CCJ icon
165
Cameco
CCJ
$38.3B
$91.4M 0.11%
1,777,862
+359,794
+25% +$19.6M
DHI icon
166
D.R. Horton
DHI
$41B
$91.2M 0.11%
652,032
-1,119,600
-63% -$187M
SCCO icon
167
Southern Copper
SCCO
$141B
$91M 0.11%
1,054,403
+345,351
+49% +$34.5M
REGN icon
168
Regeneron Pharmaceuticals
REGN
$68.8B
$90.8M 0.11%
127,400
-6,604
-5% -$5.54M
IBKR icon
169
Interactive Brokers
IBKR
$40.9B
$90.4M 0.11%
2,046,544
-3,517,840
-63% -$148M
ITCI
170
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$90.2M 0.11%
1,079,757
-81,216
-7% -$6.67M
TIP icon
171
iShares TIPS Bond ETF
TIP
$14.5B
$90.1M 0.11%
845,710
+306,340
+57% +$33.2M
GRMN
172
Garmin
GRMN
$46.9B
$90M 0.11%
436,254
-626,211
-59% -$123M
ALNY icon
173
Alnylam Pharmaceuticals
ALNY
$36.3B
$89.1M 0.11%
378,649
+315,182
+497% +$82.9M
KEYS icon
174
Keysight
KEYS
$54.5B
$88.6M 0.11%
551,381
+233,461
+73% +$37.6M
GS icon
175
Goldman Sachs
GS
$313B
$88.2M 0.11%
154,089
+145,166
+1,627% +$81M

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.